Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Short

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Pathology|December 20, 2018
shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growthHarry R Haynes, Helen L Scott, Clare L Killick-Cole, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Science Translational Medicine|August 17, 2018
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in miceEuan S Polson, Verena B Kuchler, Christopher Abbosh, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Genome Biology|February 7, 2024
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapyGeorgette Tanner, Rhiannon Barrow, Shoaib Ajaib, et al.
Cell Reports|March 7, 2025
ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activityVinton W T Cheng, Philippa Vaughn-Beaucaire, Gary C Shaw, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Science Translational Medicine|January 5, 2018
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockadeAdel Samson, Karen J Scott, David Taggart, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|December 20, 2018
shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growthHarry R Haynes, Helen L Scott, Clare L Killick-Cole, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Science Translational Medicine|August 17, 2018
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in miceEuan S Polson, Verena B Kuchler, Christopher Abbosh, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Genome Biology|February 7, 2024
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapyGeorgette Tanner, Rhiannon Barrow, Shoaib Ajaib, et al.
Cell Reports|March 7, 2025
ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activityVinton W T Cheng, Philippa Vaughn-Beaucaire, Gary C Shaw, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Science Translational Medicine|January 5, 2018
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockadeAdel Samson, Karen J Scott, David Taggart, et al.
Pageof 8